Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

An efficient approach for surveillance of childhood diabetes by type derived from electronic health record data: the SEARCH for Diabetes in Youth Study.

Zhong VW, Obeid JS, Craig JB, Pfaff ER, Thomas J, Jaacks LM, Beavers DP, Carey TS, Lawrence JM, Dabelea D, Hamman RF, Bowlby DA, Pihoker C, Saydah SH, Mayer-Davis EJ.

J Am Med Inform Assoc. 2016 Nov;23(6):1060-1067. doi: 10.1093/jamia/ocv207. Epub 2016 Apr 23.

2.

The effect of age and medical comorbidities on in vitro myoblast expansion in women with and without pelvic organ prolapse.

Price DM, Lane FL, Craig JB, Nistor G, Motakef S, Pham QA, Keirstead H.

Female Pelvic Med Reconstr Surg. 2014 Sep-Oct;20(5):281-6. doi: 10.1097/SPV.0000000000000064.

PMID:
25181379
3.

Gleaning data from disaster: a hospital-based data mining method to study all-hazard triage after a chemical disaster.

Craig JB, Culley JM, Tavakoli AS, Svendsen ER.

Am J Disaster Med. 2013 Spring;8(2):97-111. doi: 10.5055/ajdm.2013.0116.

4.

In vivo recovery of the injured anal sphincter after repair and injection of myogenic stem cells: an experimental model.

Lane FL, Jacobs SA, Craig JB, Nistor G, Markle D, Noblett KL, Osann K, Keirstead H.

Dis Colon Rectum. 2013 Nov;56(11):1290-7. doi: 10.1097/DCR.0b013e3182a4adfb.

PMID:
24105005
5.

Three nursing interventions' impact on HCAHPS scores.

Kennedy B, Craig JB, Wetsel M, Reimels E, Wright J.

J Nurs Care Qual. 2013 Oct-Dec;28(4):327-34. doi: 10.1097/NCQ.0b013e31828b494c.

PMID:
23519331
6.

Leveraging technology to promote development.

Kennedy B, Craig JB, Jury T, Wright J.

Nurs Manage. 2013 Jan;44(1):12-4. doi: 10.1097/01.NUMA.0000424023.75669.cf. No abstract available.

PMID:
23262753
7.

Allogenic myoblast transplantation in the rat anal sphincter.

Craig JB, Lane FL, Nistor G, Motakef S, Pham QA, Keirstead H.

Female Pelvic Med Reconstr Surg. 2010 Jul;16(4):205-8. doi: 10.1097/SPV.0b013e3181ec1edd.

PMID:
22453342
8.

Reconstructive pelvic surgery and plastic surgery: safety and efficacy of combined surgery.

Craig JB, Noblett KL, Conner CA, Budd M, Lane FL.

Am J Obstet Gynecol. 2008 Dec;199(6):701.e1-5. doi: 10.1016/j.ajog.2008.07.053. Epub 2008 Oct 9.

PMID:
18845294
9.

Analysis of ANA's draft scope and standards of practice for nurse administrators.

Scott ES, Craig JB.

J Nurs Adm. 2008 Sep;38(9):361-5. doi: 10.1097/01.NNA.0000323961.37168.7b. No abstract available.

PMID:
18791418
10.

A call to action: making the case for performance improvement in end-of-life care for South Carolina seniors.

Craig JB.

S C Nurse (1994). 2004 Jan-Mar;11(1):20-1. Review. No abstract available.

PMID:
15625922
11.

Phase II trial of amonafide in central nervous system tumors: a Southwest Oncology Group study.

Taylor SA, Rankin C, Townsend JJ, Craig JB, Vance RB, Solank DL, Brown TD, Jaeckle K; Southwest Oncology Group.

Invest New Drugs. 2002 Feb;20(1):113-5.

PMID:
12003186
12.

Shear fracture through the body of the axis vertebra.

Hähnle UR, Wisniewski TF, Craig JB.

Spine (Phila Pa 1976). 1999 Nov 1;24(21):2278-81.

PMID:
10562997
13.

Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: a phase II study of the Southwest Oncology Group (SWOG-9229).

Thomas CR Jr, Giroux DJ, Stelzer KJ, Craig JB, Laufman LR, Taylor SA, Goodwin JW, Crowley JJ, Livingston RB.

Int J Radiat Oncol Biol Phys. 1998 Mar 15;40(5):1039-47.

PMID:
9539558
14.

Deoxyspergualin: phase I clinical, immunologic and pharmacokinetic study.

Havlin KA, Kuhn JG, Koeller J, Boldt DH, Craig JB, Brown TD, Weiss GR, Cagnola J, Phillips J, Harman G, et al.

Anticancer Drugs. 1995 Apr;6(2):229-36.

PMID:
7795272
15.

Multicenter phase II study of weekly oral vinorelbine for stage IV non-small-cell lung cancer.

Vokes EE, Rosenberg RK, Jahanzeb M, Craig JB, Gralla RJ, Belani CP, Jones SE, Bigley JW, Hohneker JA.

J Clin Oncol. 1995 Mar;13(3):637-44.

PMID:
7533824
16.

Phase II trial of amonafide for the treatment of advanced, hormonally refractory carcinoma of the prostate. A Southwest Oncology Group study.

Marshall ME, Blumenstein B, Crawford ED, Thompson IM, Craig JB, Eisenberger M, Ahmann F.

Am J Clin Oncol. 1994 Dec;17(6):514-5.

PMID:
7977172
17.

Phase I trial of sulofenur (LY186641) given orally on a daily x 21 schedule.

Brown TD, O'Rourke TJ, Kuhn JG, Craig JB, Havlin K, Burris HA 3rd, Cagnola J, Hamilton JM, Grindey GB, Satterlee WG, et al.

Anticancer Drugs. 1994 Apr;5(2):151-9.

PMID:
8049498
18.

Phase II trial of amonafide in patients with advanced metastatic or recurrent endometrial adenocarcinoma. A Southwest Oncology Group study.

Malviya VK, Liu PY, O'Toole R, Alberts DS, Surwit E, Rosenoff S, Ward JH, Yu A, O'Sullivan J, Craig JB.

Am J Clin Oncol. 1994 Feb;17(1):37-40.

PMID:
8311005
19.

Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive days.

O'Rourke TJ, Brown TD, Havlin K, Kuhn JG, Craig JB, Burris HA, Satterlee WG, Tarassoff PG, Von Hoff DD.

Eur J Cancer. 1994;30A(3):417-8. No abstract available.

PMID:
8204374
20.

Evaluation of amonafide in disseminated malignant melanoma. A Southwest Oncology Group study.

Slavik M, Kopecky KJ, Sondak V, Craig JB, Samson MK.

Invest New Drugs. 1993 May-Aug;11(2-3):223-6.

21.

A phase I trial of trimetrexate (NSC352122) on a daily x 5 schedule in patients with refractory adult leukemia.

Rodriguez G, Brown TD, Balis FM, Craig JB, Denham CA, Kuhn JG, Havlin K, Von Hoff DD.

Anticancer Drugs. 1993 Apr;4(2):163-6.

PMID:
8490194
22.

Spinal tuberculosis with translational instability.

Shipley JA, Craig JB.

Spine (Phila Pa 1976). 1993 Mar 1;18(3):397-401. No abstract available.

PMID:
8475446
23.

Phase II trial of amonafide in advanced colorectal cancer: a SouthWest Oncology Group study.

Brown TD, Goodman PJ, Fleming T, Macdonald JS, Craig JB, Einstein AB.

Anticancer Drugs. 1993 Feb;4(1):49-50.

PMID:
8457714
24.

Neurofibromatosis of the cervical spine. A report of eight cases.

Craig JB, Govender S.

J Bone Joint Surg Br. 1992 Jul;74(4):575-8.

PMID:
1624519
25.

Evaluation of amonafide in cervical cancer, phase II. A SWOG study.

Malviya VK, Liu PY, Alberts DS, Surwit EA, Craig JB, Hannigan EV.

Am J Clin Oncol. 1992 Feb;15(1):41-4.

PMID:
1550078
26.

Phase II evaluation of amonafide in renal cell carcinoma. A Southwest Oncology Group study.

Higano CS, Goodman P, Craig JB, Kish JA, Rivkin SE, Wolf M, Crawford ED.

Invest New Drugs. 1991 Nov;9(4):361-3.

PMID:
1804814
27.

Posterior atlantoaxial arthrodesis. A simplified method.

Rodrigues FA, Hodgson BF, Craig JB.

Spine (Phila Pa 1976). 1991 Aug;16(8):878-80.

PMID:
1948372
28.

Superior facet fractures of the axis vertebra.

Craig JB, Hodgson BF.

Spine (Phila Pa 1976). 1991 Aug;16(8):875-7.

PMID:
1948371
29.

Phase I evaluation of 773U82.HCl, a member of a new class of DNA intercalators.

Havlin KA, Kuhn JG, Craig JB, Weiss GR, Koeller J, Turner JN, Luther JS, Clark G, Bair KW, Wargin W, et al.

Anticancer Drugs. 1991 Aug;2(4):357-63.

PMID:
1797191
30.

Phase I clinical and pharmacokinetic trial of flavone acetic acid.

Havlin KA, Kuhn JG, Craig JB, Boldt DH, Weiss GR, Koeller J, Harman G, Schwartz R, Clark GN, Von Hoff DD.

J Natl Cancer Inst. 1991 Jan 16;83(2):124-8.

PMID:
1703237
31.

Phase I evaluation of crisnatol (BWA770U mesylate) on a monthly extended infusion schedule.

Cobb PW, Havlin KA, Kuhn JG, Craig JB, Harman GS, Luther JS, Turner JN, Weiss GR, Tweedy DA, Koeller J, et al.

Sel Cancer Ther. 1991 Summer;7(2):85-91.

PMID:
1754731
32.

Correlation of the proliferative index of residual leukemia with outcome in patients treated with sequential high dose ara-C and asparaginase.

Powell BL, Kute TE, Craig JB, Lyerly ES, Gregory BW, Do KA, Contento MM, Capizzi RL.

Leukemia. 1990 May;4(5):316-20.

PMID:
2388477
33.

A phase II trial of high-dose cytarabine and cisplatin in previously untreated non-small cell carcinoma of the lung. A Piedmont Oncology Association Study.

White DR, Powell BL, Craig JB, Stuart RK, Schnell FM, Goldklang GA, Atkins JN, Jackson DV, Richards F 2nd, Muss HB, et al.

Cancer. 1990 Apr 15;65(8):1700-3.

PMID:
2156598
34.

Vincristine infusion with CHOP-CCNU in diffuse large-cell lymphoma.

Jackson DV Jr, Craig JB, Spurr CL, White DR, Muss HB, Cruz JM, Richards F, Powell BL.

Cancer Invest. 1990;8(1):7-12.

PMID:
2190676
35.

Phase I clinical investigation of amonafide.

Saez R, Craig JB, Kuhn JG, Weiss GR, Koeller J, Phillips J, Havlin K, Harman G, Hardy J, Melink TJ, et al.

J Clin Oncol. 1989 Sep;7(9):1351-8.

PMID:
2549205
36.

Phase II trial of a new biological response modifier (ImuVert) in advanced prostate cancer.

Osborne CK, Craig JB, Klein K, Crawford ED, Turner J.

Invest New Drugs. 1989 Jul;7(2-3):243-5.

PMID:
2793381
37.

Phase II trial of high-dose cytosine arabinoside and cisplatin in recurrent squamous carcinoma of the head and neck. A Piedmont Oncology Association Study.

Powell BL, Craig JB, Muss HB, Zekan PJ, Cooper MR, Schnell FM, Hampton JW, White DR, Smith LR, Capizzi RL.

Am J Clin Oncol. 1988 Oct;11(5):550-2.

PMID:
3177257
38.

Phase I clinical trial of carbetimer.

Hanauske AR, Melink TJ, Harman GS, Clark GM, Craig JB, Koeller JM, Boldt DH, Kantor B, Kisner DL, Orczyk G, et al.

Cancer Res. 1988 Sep 15;48(18):5353-7.

39.

Phase I and clinical pharmacology trial of crisnatol (BWA770U mesylate) using a monthly single-dose schedule.

Harman GS, Craig JB, Kuhn JG, Luther JS, Turner JN, Weiss GR, Tweedy DA, Koeller J, Tuttle RL, Lucas VS, et al.

Cancer Res. 1988 Aug 15;48(16):4706-10.

40.

Tumor necrosis factor not detectable in patients with clinical cancer cachexia.

Socher SH, Martinez D, Craig JB, Kuhn JG, Oliff A.

J Natl Cancer Inst. 1988 Jun 15;80(8):595-8.

PMID:
3373550
41.

A precision drop-fall detector for polarographic and electrocapillary work.

Craig JB, Hopkins D, Howie RA.

Talanta. 1988 May;35(5):401-2.

PMID:
18964540
43.

Phase I-II trial of acivicin in adult acute leukemia.

Powell BL, Craig JB, Capizzi RL, Richards F 2nd.

Invest New Drugs. 1988 Apr;6(1):41-4.

PMID:
3165971
44.

New anticancer agents.

Weiss GR, Arteaga CL, Brown TD, Craig JB, Harman GS, Havlin KA, Koeller JM, Kuhn JG, Von Hoff DD.

Cancer Chemother Biol Response Modif. 1988;10:85-116. Review. No abstract available.

PMID:
2484323
45.

Adjuvant chemotherapy of solid tumors.

Powell BL, Craig JB.

Am J Med Sci. 1987 Jul;294(1):33-41. Review.

PMID:
3300329
46.

Treatment of advanced colorectal carcinoma with actinomycin D, vincristine, methyl-CCNU, and methotrexate.

Craig JB, Jackson DV, Richards FR 2nd, Muss HB, White DR, Cooper MR, Stuart JJ, Spurr CL.

Am J Clin Oncol. 1987 Feb;10(1):44-6.

PMID:
3825991
47.

Phase II trial of high-dose cytarabine and cisplatin in locoregional previously untreated squamous carcinoma of the head and neck: a Piedmont Oncology Association Study.

Craig JB, Powell BL, Jackson DV, Atkins JN, Smith LR, White DR, Richards F, Capizzi RL.

Cancer Treat Rep. 1987 Feb;71(2):151-3. No abstract available.

PMID:
3802112
48.

Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignancies.

Powell BL, Muss HB, Capizzi RL, Caponera ME, White DR, Zekan PJ, Atkins JN, Jackson DV Jr, Richards F 2nd, Craig JB, et al.

Cancer Chemother Pharmacol. 1987;19(3):250-2.

PMID:
3581419
49.

Antiemetic therapy in patients treated with high-dose cytosine arabinoside.

Craig JB, Powell BL, White DR, Capizzi RL.

Oncology. 1987;44(2):90-2.

PMID:
3554086
50.

The management of nausea and vomiting in clinical oncology.

Craig JB, Powell BL.

Am J Med Sci. 1987 Jan;293(1):34-44. Review.

PMID:
3544842

Supplemental Content

Loading ...
Support Center